Key players in the Clostridium difficile infection (CDI) market include Merck & Co., Tillotts Pharma, Astellas Pharma, Pfizer, Vedanta Biosciences, MGB Biopharma, Crestone, Inc., ImmuniMed Inc., Ferring Pharmaceuticals, Deinove, Lumen Bioscience, Inc., Hospices Civils de Lyon, Wake Forest University, and others. The CDI market is projected to grow significantly due to increasing...